Literature DB >> 7907982

Anti-migraine compounds fail to modulate the propagation of cortical spreading depression in the cat.

H Kaube1, P J Goadsby.   

Abstract

Leao's cortical spreading depression (SD) is often cited as the pathophysiological substrate for the neurological symptoms of migraine with aura. If this is the case it might be expected that drugs useful as anti-migraine agents, particularly those useful in prophylaxis, may alter or prevent SD. Indeep it has been suggested that the anti-migraine compound dihydroergotamine (DHE) blocks or reduces the speed of propagation of SD in the rabbit. In this study we attempted to further investigate the effects of DHE and other anti-migraine drugs on SD by measuring cortical blood flow with laser Doppler flowmetry (CBFLDF) and cortical single unit activity in the alpha-chloralose-anaesthetised cat. The following substances were tested: DHE, acetylsalicylic acid, lignocaine, metoprolol, clonazepam and valproate. The NMDA-receptor blocker MK-801 and halothane (1.5%) were used as reference substances that reliably block SD. The outcome measures were speed of propagation of the wave of SD across the cortex and the CBFLDF increase during the hyperaemic phase of SD. Data were taken from three control episodes (60 min apart) and after drug administration. The rate of propagation was significantly reduced from the first control period (3.0 +/- 0.3 mm/min) to the subsequent 2 control observations (2.3 +/- 0.1 mm/min) even without any drug treatment. Following the control observations the test drug was administered and a further SD elicited. This fourth SD was reliably blocked by MK-801 and halothane. None of the other test drugs inhibited SD, reduced the rate of propagation or changed the amplitude of the CBFLDF increase.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7907982     DOI: 10.1159/000117004

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  18 in total

1.  Cortical spreading depression in the gyrencephalic feline brain studied by magnetic resonance imaging.

Authors:  M F James; M I Smith; K H Bockhorst; L D Hall; G C Houston; N G Papadakis; J M Smith; A J Williams; D Xing; A A Parsons; C L Huang; T A Carpenter
Journal:  J Physiol       Date:  1999-09-01       Impact factor: 5.182

2.  GABA receptors modulate trigeminovascular nociceptive neurotransmission in the trigeminocervical complex.

Authors:  R J Storer; S Akerman; P J Goadsby
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

3.  Cortical spreading depression in the feline brain following sustained and transient stimuli studied using diffusion-weighted imaging.

Authors:  Daniel P Bradley; Justin M Smith; Martin I Smith; Kurt H-J Bockhorst; Nikolas G Papadakis; Laurance D Hall; Andrew A Parsons; Michael F James; Christopher L-H Huang
Journal:  J Physiol       Date:  2002-10-01       Impact factor: 5.182

4.  Anisometropia and migraine: is the link to cortical spreading depression logically defensible?

Authors:  Vinod Gupta
Journal:  J Neurol       Date:  2006-03-06       Impact factor: 4.849

5.  [Animal models and their results in relation to the therapy of migraine].

Authors:  H Kaube; V Limmroth
Journal:  Schmerz       Date:  1996-06-17       Impact factor: 1.107

6.  Effects of antimigraine drugs on retinal spreading depression.

Authors:  M Wiedemann; V M de Lima; W Hanke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-04       Impact factor: 3.000

Review 7.  Pharmacological targeting of spreading depression in migraine.

Authors:  Katharina Eikermann-Haerter; Anil Can; Cenk Ayata
Journal:  Expert Rev Neurother       Date:  2012-03       Impact factor: 4.618

Review 8.  Spreading Depression, Spreading Depolarizations, and the Cerebral Vasculature.

Authors:  Cenk Ayata; Martin Lauritzen
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

Review 9.  Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action.

Authors:  Till Sprenger; M Viana; C Tassorelli
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

10.  Low urinary 6-sulphatoxymelatonin concentrations in acute migraine.

Authors:  Marcelo Rodrigues Masruha; Domingos Sávio de Souza Vieira; Thais Soares Cianciarullo Minett; José Cipolla-Neto; Eliova Zukerman; Luiz Celso Pereira Vilanova; Mario Fernando Prieto Peres
Journal:  J Headache Pain       Date:  2008-07-02       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.